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Sox8 is a member of the Sox family of developmental
transcription factor genes and is closely related to Sox9,
a key gene in the testis determination pathway in mam-
mals. Like Sox9, Sox8 is expressed in the developing
mouse testis around the time of sex determination, sug-
gesting that it might play a role in regulating the expres-
sion of testis-specific genes. An early step in male sex
differentiation is the expression of anti-Mu¨llerian hor-
mone (AMH) in Sertoli cells. Expression of the Amh gene
during sex differentiation requires the interaction of
several transcription factors, including SF1, SOX9,
GATA4, WT1, and DAX1. Here we show that SOX8 may
also be involved in regulating the expression of Amh.
Expression of Sox8 begins just prior to that of Amh at 12
days post coitum (dpc) in mouse testes and continues
beyond 16 dpc in Sertoli cells. In vitro assays showed
that SOX8 binds specifically to SOX binding sites within
the Amh minimal promoter and, like SOX9, acts syner-
gistically with SF1 through direct protein-protein inter-
action to enhance Amh expression, albeit at lower levels
compared with SOX9. SOX8 and SOX9 appear to have
arisen from a common ancestral gene and may have
retained some common functions during sexual devel-
opment. Our data provide the first evidence that SOX8
may partially compensate for the reduced SOX9 activity
in campomelic dysplasia and substitute for Sox9 where
Sox9 is either not expressed or expressed too late to be
involved in sex determination or regulation of Amh
expression.
Gonadal sex determination in eutherian mammals begins
when the indifferent gonad responds to an unidentified signal
resulting in the expression of Sry in males followed by the
up-regulation of Sox9 expression in pre-Sertoli cells. Sertoli
cells are the primary supporting cell type surrounding the
germ cells and are required for further differentiation of the
testes, including signaling to the steroidogenic Leydig cell lin-
eage. One of the critical steps in male development is the
regulation of expression of the anti-Mu¨llerian hormone gene
(Amh) in Sertoli cells. AMH1 is responsible for the regression of
the Mu¨llerian duct in males and marks the start of the hormo-
nal cascade required for male sexual differentiation. Deletion of
the Amh gene results not in full sex reversal but pseudoher-
maphroditism in male mice (1), confirming its involvement in
sex differentiation rather than sex determination. Expression
of Amh results from the interplay of several factors on the
360-bp Amh minimal promoter, including SOX9, the Wilms
tumor-associated protein WT1, the GATA-binding protein
GATA4, the orphan nuclear receptor DAX1 (NR0B1 (2)), and
the steroidogenic orphan nuclear receptor SF1 (Ad4BP,
NR5A1). SF1 is central to the expression of Amh and coopera-
tively interacts with WT1 (3), GATA4 (4), and the HMG domain
of SOX9 (5). How or, indeed, whether all four factors interact
together on the Amh promoter is still unknown.
A number of SOX transcription factors have been shown to
play important roles during sex determination and differenti-
ation. For example, the Y-encoded testis-determining factor
SRY is believed to be involved in directing the differentiation of
the gonadal supporting cell lineage into Sertoli cells and thus
acts as the sex determination switch in eutherian mammals
(for review see Ref. 6). Complementary results have also impli-
cated SOX9 as a male-specific sex determinant, with deletion
or disruption of human SOX9 often resulting in XY sex reversal
(7, 8) and overexpression of Sox9 inducing female to male sex
reversal in mice (9).
Recently we showed that Sox8, a gene closely related to Sox9,
is expressed in the developing brain, branchial arches, limbs,
and kidneys and sex-specifically expressed in the testes (10).
Structural comparison of SOX8 and SOX9 revealed consider-
able conservation, particularly within the HMG domain and
the C-terminal trans-activation domain. We now report that
Sox8 and Sox9 have overlapping expression patterns during
testis development in mice and that both proteins bind specif-
ically to the SOX binding site in the Amh promoter and interact
with SF1 to synergistically enhance the expression of Amh.
Thus we conclude that SOX8 may act redundantly with SOX9
to activate Amh expression during testis development.
MATERIALS AND METHODS
In Situ Hybridization—Whole-mount in situ hybridization was car-
ried out essentially as described previously (11). Three Sox8 riboprobes
corresponding to nucleotides 156–1447, 2746–2855, and 3595–4424
(GenBankTM accession number AF191325) were used together for Sox8
whole-mount in situ hybridization, to optimize the signal. The Oct4
riboprobe was generated from a plasmid kindly donated by Prof. Peter
Rathjen and corresponds to nucleotides 594–1055 (GenBankTM
NM_013633). Probes for Amh and Sox9 were synthesized as described
previously (12, 13). Section in situ hybridization was carried out on
12-m, serial sections of fresh-frozen 15 dpc testes and probed as
previously described (14). Fluorescent color development was per-
formed in place of NBT/BCIP staining and was achieved using “Fast
red” tablets (Roche Applied Science) according to the manufacturer’s
instructions. Post in situ immunofluorescence involved washing the
sections in 0.1 M Tris-HCl (pH 8.2), followed by three washes in phos-
phate buffered saline (PBS, 5 min each). The sections were blocked for
1 h in 1% heat-inactivated sheep serum (HISS) in PBS. Anti-SOX9
antibody (15), diluted 1/200, was incubated with the sections overnight
at 4 °C in 1% HISS, 0.1% Triton X-100 in PBS. Sections were washed
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three times in PBS, blocked for 5 min at room temperature in 1% HISS
in PBS, and probed with anti-rabbit IgG Alexa Fluor 488 (Molecular
Probes) for 30 min at room temperature in 1% HISS, 0.1% Triton X-100
in PBS. Finally, sections were washed as before in PBS, mounted in
50% glycerol in PBS, and photographed.
Cell Culture and Transfection Assays—Trans-activation domain
analysis of GAL fusion constructs were performed as previously de-
scribed (10). Co-transfection experiments were performed in triplicate
using COS7 cells, in 12-well tissue culture plates containing 500 ng of
reporter vector (360-bp Amh promoter in pGL3-basic, see Ref. 16).
Transfection controls included 500 ng of pGL3-control. Transfections
were performed using Cytofectene (Bio-Rad) according to the manufac-
turer’s instructions. Full-length SF1, SOX9, and SOX2 expression vec-
tors were constructed by sub-cloning the open reading frames from
RSV/Ad4BP (16), Sox9-pSG5 (17), and cSox2-pCMV/SV1 (18) into
pcDNA3.1 (Invitrogen). Equal amounts of SOX8 (10), SOX9, and
SOX2 expression constructs (20 ng per well) with or without SF1
expression construct (0 or 50 ng per well) were transfected, with the
total amount of CMV-containing vector standardized by the addition of
different amounts of pcDNA3.1 to each transfection (total amount of
CMV promoter-containing vector was 70 ng per replicate). Luciferase
assays were performed essentially as previously described (10) with the
following alteration: 80 l of the 100-l cell lysate was added to 100-l
Luciferase assay reagent (Roche Applied Science).
The statistical analysis performed on transfection data include a
two-way, paired analysis of variance followed by the Student-Newman-
Keuls post hoc analysis with a 95% confidence score. These analyses
were performed using StatView 5.0.1 (SAS Institute Inc.).
Electrophoretic Mobility Shift Assay—EMSA analysis was performed
using recombinant, bacterially expressed GST fusion proteins of full-
length SF1, SOX2, SOX8, and truncated SOX9 (amino acids 1–440).
Recombinant plasmids were constructed using the vector pGEX-KG
(19) for SOX2, -8, and -9 and pGEX-4T-3 (Amersham Biosciences) for
SF1.
Wild-type and mutated Amh promoter fragments were cloned by
PCR into the pGEM-Teasy vector (Promega) using MIS-wt, MIS-R1,
MIS-R2, and MIS-R3 (20) as templates and the following primers:
AMHpro-for (AAG CTT GAT ATC GAA TTC CTG) for amplifying R1,
R2, and R3 fragments, AMHpro-for2 (AGT GGA TCC CCC GGG CTG)
for amplifying the wild-type fragment, together with AMHpro-rev (GGA
ATT CGC CCC CTA TCA ACA CCA AA). Fragments were cut out of the
respective constructs with EcoRI and gel-purified. Oligonucleotide
probes (S2) harboring two SOX2 binding sites had the following se-
quence: GGG ATC CCT TTG TGT CTG GCA ATG CAC AAT ATT G.
Fragments as well as oligonucleotide probes were labeled using
[-32P]ATP and T4 polynucleotide kinase. Binding reactions were per-
formed in a final volume of 30 l in binding buffer (100 mM KCl, 1 mM
MgCl2, 10 mM Tris, pH 7.5, 4% glycerol, 0.1% Triton X-100, 1 mg/ml
bovine serum albumin, 1 g of poly(dI-dC)/poly(dA-dT), 0.5 mM dithio-
threitol). Reaction mixtures containing 100 ng of purified protein were
preincubated for 10 min at room temperature followed by the addition
of end-labeled probe. After 20-min incubation at room temperature,
DNA-protein complexes were resolved by electrophoresis on 4% poly-
acrylamide gels (containing 2.5% glycerol) at 150 V for 2 h in 0.5 TBE
buffer.
GST Pull-down Assays—Fragments of SOX8 were generated using
PCR and cloned into the pcDNA3.1 expression vector. 35S-Labeled
proteins were generated in vitro using the T7-TNT system (Promega).
GST-SF1 fusion protein was purified from BL21 cells as described
previously (21) and left attached to glutathione-agarose beads. Bound
SF1 fusion protein was then incubated with different 35S-labeled pro-
teins in NTEN buffer (20 mM Tris-Cl, pH 7.5, 100 mM NaCl, 1 mM
EDTA, and 0.5% Nonidet P-40) at 4 °C for 1 h. The beads were then
washed four times with NTEN, and bound proteins were eluted with 6
Laemmli buffer, boiled, analyzed on a 15% SDS-PAGE gel, and visual-
ized by autoradiography.
RESULTS
Sox8 Expression in Developing mouse Testes—We have pre-
viously shown expression of Sox8 in mouse fetal testes at 13.5-
day post coitum (dpc) (10). To determine the timing of expres-
sion of Sox8 in the testis, we performed a detailed in situ
hybridization analysis of gonads at different developmental
stages spanning sex determination and differentiation
(11.5–16 dpc). Sox8 transcripts were first detected in the center
of the testis at 12 dpc (25 tail somites), before cord formation
(Fig. 1A). The expression domain expanded to include the ros-
tral and caudal poles by 12.5 dpc and continued in testis cords
beyond 16 dpc, with the strongest expression observed around
13.5–15 dpc. Expression of Sox8 in the ovary was undetectable
from 11 to 16 dpc (Fig. 1A).
We next compared the expression of Sox8 with that of Sox9
and Amh, two key genes involved in testis development, to shed
light on the potential regulatory relationships between these
genes. At each stage studied, left and right genital ridges or
testes from the same fetus were assessed in parallel for Sox8
and Sox9 expression. Sox8 and Amh expression was compared
in other samples in a similar fashion (Fig. 1B). As a control, left
and right gonads from the same fetus were assessed for differ-
ences in expression of each gene, and equal levels were ob-
served in each case (data not shown).
The up-regulation of Sox9 expression was first evident at
11.5 dpc (18 tail somites, Fig. 1B), with expression continuing
in the testis cords at 13 dpc through to 16 dpc. Similar to Sox8,
expression of Sox9 began in the center of the testis and ex-
panded to both poles by 12 dpc, when the first transcripts of
Sox8 were detected in the center of the testis. Thus, Sox9
expression precedes that of Sox8 during sex determination by
some 12 h. Sox8 and Amh expression patterns showed consid-
erable overlap, with Amh transcripts first detected at 12 dpc in
a patch of cells that was spatially more restricted than that
expressing Sox8. The expression of Amh began in the center of
the testis and encompassed the poles within 24 h; between 12
and 12.5 dpc the expression domain of Sox8 was more extended
than that of Amh (Fig. 1B), suggesting that expression of the
former preceded that of the latter. These data, combined with
the localization of transcripts of all three genes to the develop-
ing testis cords, are consistent with the regulation of Amh
expression by Sox9 and Sox8 in vivo.
Previous studies have established that Sox8 expression is
associated with developing testis cords in mice (10, 22). To
further test the hypothesis that Amh expression may be regu-
lated by SOX8 in addition to SOX9, it was necessary to deter-
mine whether Sox8 is expressed in the Sertoli or germ cell
component of the testis cords, because both Sox9 and Amh are
known to be expressed in developing Sertoli cells (13, 17, 23).
We performed in situ hybridization on serial sections of 15 dpc
testes using probes for Sox8, Sox9, Amh, or the germ cell
marker Oct4. Characteristic Sertoli cell expression was clearly
evident for Amh, because it was distinct from the expression
pattern of Oct4 (Fig. 2A). This analysis showed that Sox9 and
Sox8 are also expressed in Sertoli cells (Fig. 2A). To confirm the
expression of Sox8, Sox9, and Amh in the same cells, we per-
formed double-labeling experiments, detecting Sox8 or Amh
transcripts by in situ hybridization and SOX9 protein by im-
munofluorescence (Fig. 2B). All three genes were detected in
the same cell type, as evident from the co-localization of signal
observed in each case (Fig. 2B).
Binding of SOX8 to Amh Promoter Sequences—Based on the
overlapping expression of Sox8 and Amh in Sertoli cells, we
wished to determine whether SOX8 was capable of binding the
critical SOX binding site in the Amh promoter (20). We per-
formed an electrophoretic mobility shift assay (EMSA) with
wild-type and mutant Amh promoter fragments spanning both
the established SOX and SF1 binding sites (Fig. 3A). As ex-
pected, SF1 bound to promoter fragments with a wild-type SF1
binding site but not to those with a mutant SF1 site or an
oligonucleotide (S2) harboring SOX2 binding sites (Fig. 3B,
lanes 1–5), and SOX9 bound to wild-type but not mutant SOX
binding site fragments (Fig. 3B, lanes 11–14). In these experi-
ments, SOX8 also bound specifically to probes containing the
wild-type but not the mutated SOX site (Fig. 3B, lanes 6–9),
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thus demonstrating sequence-specific DNA binding of SOX8
within the Amh minimal promoter. In contrast, the unrelated
SOX2 protein was not able to bind to any of the Amh promoter
fragments (Fig. 3B, lanes 16–19). All three SOX proteins bound
to the SOX2 binding site oligonucleotide S2 (Fig. 3B, lanes 10,
15, and 20). SOX8 DNA binding in vitro was consistently
weaker than that shown by SOX9.
Activation of the Amh Promoter by SOX8 and SF1—SOX9
has previously been shown to act synergistically with SF1 to
activate transcription from the minimal Amh promoter in cul-
tured cells (5). Considering the temporal and spatial expression
of Sox8, and the sequence-specific DNA binding to the Amh
promoter, we tested directly whether SOX8 is able to stimulate
Amh promoter activity. To investigate potential cooperative
trans-activation between SF1 and SOX proteins, we performed
co-transfection experiments similar to those described by de
Santa Barbara and co-workers studying SOX9 and SF1 (5).
COS7 cells were transfected with an Amh promoter-reporter
construct and co-transfected with expression constructs for SF1
and the SOX proteins SOX8, SOX9, or SOX2.
In agreement with previous studies (5), SOX9 and SF1 syn-
ergistically activated transcription from the Amh promoter
4-fold above the levels observed with the reporter vector alone
(Fig. 4A). SOX8 was also able to cooperatively activate tran-
scription in the presence of SF1 (Fig. 4A). The synergistic
activation of the Amh promoter by SF1 in combination with
either SOX8 or SOX9 was found to be statistically significant
with a confidence value of 0.05. In over a dozen independent
experiments, the activation levels achieved by SOX8 and SF1
were consistently lower than those achieved by SOX9 and SF1,
although the difference was not always statistically significant
(Fig. 4 (A and B) and data not shown). The unrelated SOX
protein SOX2 was found to have no effect on Amh expression in
the presence or absence of SF1 (Fig. 4A).
Finally, we also assessed whether SOX8 and SOX9 are able
to act synergistically on the Amh promoter. The level of trans-
activation achieved in the presence of SOX8, SOX9, and SF1
(around 5-fold, Fig. 4B) was similar to that observed for SOX9
FIG. 1. Expression of Sox8, Sox9,
and Amh during sex determination.
A, whole-mount in situ hybridization of
Sox8 in developing testes (male symbol)
and ovaries (female symbol). Developmen-
tal ages of gonads are labeled above. B,
comparative expression of Sox8, Sox9,
and Amh. Each column contains accu-
rately staged gonads with the develop-
mental ages labeled above. The top two
rows represent pairs of left and right male
gonads from the same embryos probed
with Sox8 (first row) or Sox9 (second row).
The lower two rows represent pairs of left
and right male gonads from the same em-
bryos probed with Sox8 (third row) or
Amh (fourth row). Black lines represent
schematically the timing of expression of
the three genes.
SOX8 Activation of the Amh Promoter 28103
 at UQ Library on October 16, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
and SF1 (difference not statistically significant). The small
increase in trans-activation in the presence of all three factors
shows that SOX8 and SOX9 do not act synergistically.
Potency of the SOX8 Activation Domain—Activation of the
Amh promoter in the presence of SOX8 and SF1 was consis-
tently lower than that observed with SOX9 and SF1. To further
investigate this observation, we compared directly the relative
trans-activation domain potency of SOX8 and SOX9 (Fig. 4C).
The entire coding regions C-terminal to the HMG domains of
SOX8 and SOX9 were fused to the GAL4 DNA binding domain
and used in trans-activation domain analyses, similar to those
performed in earlier studies (10, 15). These regions contain a
conserved trans-activation domain at the C terminus and a
second non-conserved trans-activation region (10, 24). The C
terminus of SOX9 consistently showed an 80-fold increase in
trans-activation compared with GAL alone, whereas SOX8 en-
hanced expression 10-fold (Fig. 4C). Both fusion proteins
were expressed at similar levels as detected by Western anal-
ysis (data not shown). These data suggest that SOX8 has a
weaker C-terminal trans-activation domain than SOX9.
SOX8 and SF1 Interact Directly via the HMG Domain—
Target specificity of SOX proteins is thought to be mediated by
direct interaction with cell type-specific partner proteins and
cofactors (25, 26). To support the in vivo significance of the
observed synergy between SOX8 and SF1, we next tested the
ability of SOX8 and SF1 to interact directly. Radiolabeled full-
length SOX8 and fragments representing the N terminus,
HMG domain, and C terminus were produced and incubated
with GST-SF1 fusion protein attached to glutathione-Sepha-
rose resin. After several washes, only full-length SOX8 and the
HMG domain fragment remained bound by GST-SF1 (Fig. 5).
These data confirm that SOX8 can bind to SF1 in vitro and that
this interaction is mediated by the HMG domain of SOX8.
Interestingly, SOX2 was also found to bind SF1 (Fig. 5), as
might be expected for an interaction mediated by the highly
conserved HMG domain. This latter observation is unlikely to
FIG. 2. Sertoli cell expression of
Sox8. A, in situ hybridization of 15 dpc,
serial, 12-m cryosections probed with
Sox8 (top row, left two panels), Sox9 (top
row, right two panels), Amh (lower row,
left two panels), and the germ cell marker,
Oct4 (lower row, right two panels). Bar 
0.1 mm. Open boxes represent regions en-
larged in the neighboring right panel. B,
co-labeling of Sox8, Amh, and SOX9. The
upper panel series shows Sox8 in situ hy-
bridization (red), SOX9 immunofluores-
cence (green), and an overlay with yellow
representing overlapping signals. The
lower panel series shows Amh in situ hy-
bridization (red), SOX9 immunofluores-
cence (green), and an overlay with yellow
representing overlapping signals.
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have any in vivo relevance, because SOX2 is not co-expressed
with SF1 in Sertoli cells of the developing testis2 and does not
activate transcription from the Amh promoter (Fig. 4A). Taken
together, our observations suggest that SOX8 and SF1 can bind
to adjacent sites on the Amh promoter and form a complex that
is able to activate transcription from the Amh promoter in
Sertoli cells.
DISCUSSION
The involvement of SOX genes in sex determination and
differentiation is well documented, with the founding member
of the family, Sry, shown to be the critical sex determining gene
on the mammalian Y chromosome (27), and heterozygous
SOX9 mutations often resulting in XY sex reversal in humans
(7, 8). One of the early steps in sex differentiation is the up-
regulation of Amh expression in Sertoli cells, which results in
regression of the female-specific Mu¨llerian duct and marks the
onset of the male-specific hormonal pathway. All of the regu-
latory elements required for Amh expression during sexual
differentiation are located within a relatively small, 180-bp
promoter fragment (22), making this promoter particularly
amenable to studying gene regulation. At least five factors are
known to be involved in regulating Amh expression during sex
differentiation. SF1 is believed to play a central role and has
been shown to synergistically interact with SOX9 (5), GATA4
(4), or WT1 (3) to activate transcription, whereas interaction
with DAX1 (2, 3) results in repression of Amh expression. In
this study we show that SOX8 is also able to synergize with
SF1 to enhance expression of Amh.
Sox8, Sox9, and Amh all show similar spatiotemporal expres-
sion patterns in developing mouse gonads, with expression
beginning in the center of the genital ridge and spreading to
the poles within 12 h. This is the first evidence that the expres-
sion of all three genes begins at, and expands from, the center
of the developing testis, and is congruent with recent evidence
that Sry expression also occurs as a wave beginning in the
center of the testis and moving to the anterior and then poste-
rior pole (28). The similar spatial and temporal dynamics of
expression of Sry, Sox9, Sox8, and Amh provides support for a
link between these genes in the molecular pathway of testis
development. Sox8 expression is up-regulated in Sertoli cells
around 12 dpc, 12 h after Sox9 and just before Amh. These
observations are consistent with the possibility that Sox8, like
Sox9, can contribute to the regulation of Amh transcription in
vivo.
This hypothesis is further supported by our results relating
to SOX8 DNA binding and transcriptional activation in vitro.
Our EMSA experiments demonstrated that SOX8 and SOX9
were able to bind as a monomer and, surprisingly, also as a
dimer to two adjacent SOX binding sites in the Amh promoter.
This is the first example of a paired SOX binding site in the
promoter of a gene involved in sex differentiation. The binding
to these sites is specific to SOX8 and SOX9, because the unre-
lated SOX2 protein did not bind. Similarly, it has been shown
that SOX10 is able to bind to DNA as a monomer and a dimer
(29). All three proteins (SOX8, -9, and -10) belong to the group
E of SOX proteins, which contain a conserved 40-amino acid
domain adjacent and N-terminal to the HMG-box. For SOX10 it
has been demonstrated that this domain is essential for coop-
erative binding to response elements (30). So far, paired SOX
binding sites have been only identified in the regulatory re-
2 G. Schepers, M. Wilson, D. Wilhelm, and P. Koopman, unpublished
observations.
FIG. 3. SOX8 binding to the Amh
promoter. A, schematic representation
of the Amh promoter DNA probes (wt, R1,
R2, and R3 (20)) used in the EMSA. The
confirmed SOX and SF1 binding sites are
highlighted in black. The newly identified
SOX binding site is marked by a box. The
co-ordinates of the ends of the fragments
and of the binding sites are listed below in
base pairs relative to the ATG start codon
for the Amh open reading frame. Site-
directed mutations in the Amh promoters
are represented in boldface and are un-
derlined, with wild-type sequences repre-
sented by an unbroken line. B, EMSA of
wild-type and mutant Amh promoter
fragments with GST fusion proteins of
SF1 (left panel), SOX8 (second panel),
SOX9 (third panel), or SOX2 (right panel).
Arrows indicate SF1, SOX8, and SOX9,
respectively, binding as monomer. Arrow-
heads indicate SOX8 and SOX9 dimers.
S2, oligonucleotide harboring two SOX2
binding sites (see “Material and Methods”).
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gions of a number of target genes involved in chondrogenesis,
such as Col2a1 and Col11a2 (31, 32). Mutation of these en-
hancer sequences has different functional consequences de-
pending on which of the two SOX binding sites is mutated (29).
Mutation of the primary SOX binding site (148 to 154 bp) in
the Amh promoter results in pseudohermaphroditism in trans-
genic mice, demonstrating that this site is essential for Amh
expression in vivo (20). The functional significance of the newly
identified, adjacent SOX binding site, and whether SOX8
and/or SOX9 binds in vivo, is still unknown.
Similar to SOX9, SOX8 acts synergistically with SF1 to
activate transcription from the Amh promoter, although the
levels are consistently lower than those achieved by SOX9 with
SF1. The reduced efficiency of SOX8 to trans-activate tran-
scription in the presence of SF1 is most likely due to a combi-
nation of its apparent lower DNA binding affinity to Amh
promoter sequences and its less potent trans-activation do-
mains, compared with SOX9. Our observations suggest that
adjacent binding as well as physical interaction are important
for the synergy between SOX8 and SF1 in transcriptional ac-
tivation, as it is for SOX9 and SF1.
Sox8 may perform functions additional to regulating Amh
during sex determination. For instance, the expression of Sox9
is activated either directly or indirectly by SRY, but Sox9
expression continues long after the cessation of Sry expression
(17, 23), suggesting that another element is required to main-
tain Sox9 expression. Sequence and cell transfection analyses
have revealed a SOX binding site in the Sox9 promoter that is
essential for maximal activity in gonadal somatic cells (33). Our
FIG. 4. Trans-activation of the Amh
promoter by SOX8 and SF1. A, co-
transfection of SOX8, SOX9, SOX2, and
SF1 expression constructs with an Amh
promoter reporter construct. The lanes
and expression constructs transfected in
each sample are represented below with
“” indicating the addition and “” the
omission of the expression construct. The
-fold activation was compared with
the reporter construct alone, lane 1. Error
bars show S.E., with asterisks indicat-
ing samples significantly different be-
tween the presence and absence of SOX
proteins. B, co-transfection of SOX8,
SOX9, and SF1 with an Amh promoter
reporter construct. The lanes, expression
constructs transfected, -fold activation,
error bars, and asterisks are indicated as
for part A. C, SOX8 and SOX9 trans-acti-
vation domain comparison. GAL4 fusion
constructs are shown on the left. The
numbers represent mouse SOX8 or SOX9
amino acids fused with the GAL4 DNA
binding domain. The right panel shows
luciferase activity produced by each con-
struct, relative to pLUC  1, with stand-
ard error calculated from three replicate
transfections.
FIG. 5. SOX8 interacts directly with SF1. Full-length SOX8,
SOX9, SOX2, or fragments of SOX8 protein (SOX8-N, SOX8-HMG, or
SOX8-C, as shown in the lower diagram) were produced in vitro. Ra-
diolabeled proteins were incubated with either GST-SF1 (A) or GST-
only (B). Electrophoresis of radiolabeled input proteins confirmed that
all were intact and produced at similar levels (data not shown). Full-
length SOX8, SOX9, SOX2, and fragments of SOX8 encoding the HMG
domain can be seen to bind to SF1, indicating that this interaction is
mediated by the HMG domain.
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observations suggest SOX8 as a candidate for a factor required to
maintain Sox9 expression during sex differentiation.
Shen and Ingraham (34) showed recently that SOX8, like
SOX9, can bind to a specific site in the Sf1 promoter. However,
SOX8 was found to bind with much less affinity than SOX9,
and was not able to specifically induce transcription from this
promoter in vitro. These results provide an intriguing counter-
point to our present observations relating to Amh regulation,
and it thus appears that the two SOX proteins are not able to
act interchangeably in all situations.
SOX8 appears to be capable of performing the same or sim-
ilar function as SOX9 in regulating Amh expression during sex
differentiation, but the overall extent of functional overlap
between the two proteins remains to be determined. Functional
redundancy has been demonstrated or proposed for a number
of SOX proteins (18, 35–37) and is considered to reflect evolu-
tion in progress. Often the genes involved are closely related
and in the process of diverging, where their co-expression and
shared functionality are a result of a recent common ancestor
(38), as may be the case for Sox8 and Sox9 (39). They may also
share common functions in other tissues where expression is
overlapping, such as in the developing CNS, spinal cord, and
kidneys (10, 12).
Sox8 and Sox9 also show complementary expression pat-
terns in numerous developing tissues, including the developing
somites and skeleton. In the somites, Sox9 expression is ob-
served in the sclerotome (12) and Sox8 in the dermomyotome
(40). Similarly, Sox9 is expressed in chrondrocytes (12) and
Sox8 in osteoblasts (41) during skeletal development. These
complementary expression patterns may reflect the adoption of
unique functions that were originally performed by a common
ancestor. In teleosts, a lineage-specific, genome-wide duplica-
tion has resulted in two copies of many genes, and is often used
as a model of gene duplication and divergence (38). Two Sox9
genes have been identified in zebrafish, where the expression of
the duplicate genes is distinct but overlapping in the brain,
head skeleton, and fins (42). Considering these issues, we pro-
pose that the conserved function between SOX8 and SOX9 in
regulating Amh expression may be an evolutionary remnant.
The lower efficiency of SOX8 in regulating Amh expression
suggests that this role may no longer be important in vivo,
leaving SOX9 as the primary SOX protein required for this
role, at least in eutherian mammals. This view is further con-
firmed with the apparent lack of sex reversal or gonadal dys-
genesis observed in Sox8 knockout mice (43).
In view of the biochemical similarity between SOX8 and
SOX9, these proteins may share other roles during sexual
development. This may explain the inconsistent rate of sex
reversal seen in campomelic dysplasia patients (44), who have
mutations in one copy of SOX9. We hypothesize that SOX8 at
least partially ameliorates the haploinsufficiency of SOX9 in
XY campomelic dysplasia patients who do not undergo sex
reversal, with the penetrance of this effect likely to be influ-
enced by other genetic modifiers.
It is clear that the SOX binding site in the Amh promoter is
functionally important, because mutations in this site severely
disrupt Amh expression levels in vivo (20). Previously it has
been assumed that this site is important solely due to binding
of SOX9. However, the ability of SOX8 to enhance expression of
Amh in mammals through interaction with this site may ex-
plain the paradox in chicken and alligator sex determination,
where Amh is expressed before Sox9 (45, 46). In these species,
SOX8 may be important for the regulation of Amh expression.
Amh is also expressed in granulosa cells of the adult mamma-
lian ovary in the absence of Sox9 expression (17, 47). This may
represent another cellular context where SOX8 could contrib-
ute to the control of Amh expression. These possibilities are
currently under investigation.
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